CHEN, XIANGYANG,GAO, YINGXIANG,LIU, CHONG,NI, HAIHONG,MULVIHILL, MARK
申请号:
SG11201602070T
公开号:
SG11201602070TA
申请日:
2014.09.29
申请国别(地区):
SG
年份:
2016
代理人:
摘要:
Compounds of Formula I, as shown below and defined herein: and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune disease mediated at least in part by Bruton's Tyrosine Kinase (BTK).